QCM Cayman’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,514
Closed -$477K 151
2017
Q3
$477K Buy
+2,514
New +$478K 1.22% 12
2016
Q4
Sell
-1,597
Closed -$200K 173
2016
Q3
$200K Buy
+1,597
New +$206K 0.22% 156
2014
Q2
Sell
-5,977
Closed -$595K 268
2014
Q1
$595K Buy
+5,977
New +$541K 0.13% 96

Other funds holding ELV

QCM Cayman's ELV Position: Q4 2017 in Review

QCM Cayman sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 2,514 shares — an estimated $477K sold.

QCM Cayman first reported a position in ELV in Q1 2014 and held it in 3 quarters. The position peaked at $595K in Q1 2014. 910 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • QCM Cayman reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
  • QCM Cayman sold 2,514 Elevance Health shares in Q4 2017, an estimated $477K.
  • QCM Cayman first reported a position in Elevance Health in Q1 2014 and held it in 3 quarters.
  • QCM Cayman's Elevance Health position peaked at $595K in Q1 2014.
  • 910 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on QCM Cayman's 13F filing for Q4 2017, filed 14 Feb 2018.